Skip to content

Speakers

Adonis GEORGIADIS

Minister of Health, Hellenic Ministry of Health

Marco MARCHETTI*

Director HTA Unit Italy (AGENAS), Co-Chair of the Interest Group of HTA International

Róisin ADAMS

Head at HTA Strategy and External Engagement, National Centre for Pharmacoeconomics (NCPE), Ireland

Panos KANAVOS*

Associate Professor, Deputy Director, LSE Health, Department of Social Policy, London School of Economics

Yannis NATSIS

Director of the European Social Insurance Platform (ESIP)

Nikos MANIADAKIS

Professor of Health Services Evaluation, Management & Policy, Department of Public Health Policy, Univ. of West Attica

Romina SIATERLI

Policy and Communications Excellence Lead, Roche Hellas, and Member of the Policy Working Group, PhARMA Innovation Forum

Babis KARATHANOS

Special Advisor to The Minister of Health

Aris ANGELIS

Secretary General of Strategic Planning, Hellenic Ministry of Health

Flora BACOPOULOU

President of The HTA Committee, Associate Professor of Pediatrics – Adolescent Medicine, NKUA

Athanasios CHANTZARAS

Member of the HTA Committee, Adjunct Lecturer of Health Economics, NKUA (University of Athens MBA)

Christian RODSETH

Vice-President PhARMA Innovation Forum, Managing Director, Janssen Greece, Poland & Romania

Olympios PAPADIMITRIOU

President of the Association of Pharmaceutical Companies of Greece (SFEE) & General Manager, Novo Nordisk Hellas

Zoe STEFANIDOU

Biologist, MSc In Health Policy, Head of International Market Access, ELPEN

Nikos DEDES

Secretary, GPA, President of the Association of People Living with HIV/AIDS “Positive Voice”

Panos STAFYLAS

Cardiologist / HTA Consultant, Scientific Director Of HealThink, Greece

Marios THEMISTOCLEOUS

Deputy Minister of Health, Hellenic Ministry of Health

Anastasia CHALKIDOU

Assoc. Director HealthTech, National Institute for Health & Care Excellence, Co-Chair Med. Devices Interest Group, HTAi

Antonis KAROKIS

External Affairs Director, MSD

George KAPETANAKIS

Chairman of The Board of Directors ELLOK, President of the Pieria Cancer Patients Association

Panagiota MITROU

Internist-Diabetologist, Head, Independent Dept of Therapeutic Protocols And Patient Registries, Ministry of Health

Dimitrios ATHANASIOU

EMA PCWP Member, President Rare Diseases Greece, GPA WDO, 95, Board Member

Lotte STEUTEN

Deputy Chief Executive, Office of Health Economics, London, UK, Hon. Visiting Prof. at City, London Univ. UK

Spiros VAMVAKAS

Head of Scientific Advice, European Medicines Agency (EMA)

Christos GEORGAKOPOULOS

Market Access Director, Hellenic Association of Pharmaceutical Companies (SFEE)

Anja SCHIEL

Special Adviser, Lead Methodologist In Regulatory And Pharmacoeconomic Statistics, NoMA

Anne WILLEMSEN*

Co-chair of the HTA Subgroup on JCA, & Senior Advisor at Zorginstituut Nederlands

Yannis YFANTOPOULOS

Academic Coordinator MBA, University of Athens Health Services Management

Nikos POLYZOS

Professor of Health Services Management, Department of Medicine, University of Thrace

Maria KALOGEROPOULOU

Associate Director Value Access, Health Policy & RWE, IQVIA

Vasileios KOURAFALOS

Pharmacist, Head of the Dep. οf Monitoring & Utilization οf Controls, EOPYY, Member οf Med. Negotiation Com.

Hosted by

Boussias Events

A leading European B2B trade publishing, conferences and awards organizing company, committed to quality and innovation.

Share on

Booths

HELP DESK

Αντιμετώπιση τεχνικών προβλημάτων (Δίκτυο/Εικόνα/Ήχος